Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy
Sara E. Looby(Cancer Research And Biostatistics), Markella V. Zanni(Harvard University), Kristine M. Erlandson(University of Colorado Denver), Heather J. Ribaudo(Cancer Research And Biostatistics), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Edgar T. Overton(University of Alabama at Birmingham), Esper G. Kallás(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Amy Kantor(Cancer Research And Biostatistics), Pamela S. Douglas(Duke University), Evelynne S. Fulda(Cancer Research And Biostatistics), Steven Grinspoon(Massachusetts General Hospital), Michael T. Lu(Cancer Research And Biostatistics), Alice Thornton(University of Kentucky), Carlos Malvestutto(The Ohio State University Wexner Medical Center), Gerald S. Bloomfield, Mar Masiá(Universidad de Alcalá), Jacqueline M Flynn(Temple University), Tricia H. Burdo(Temple University), Emma M. Kileel(Boston University), Judith S. Currier(University of California, Los Angeles), Kathleen V. Fitch(Harvard University), Mandy D. Smith(Temple University), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Michelle Cespedes(Icahn School of Medicine at Mount Sinai)
Cited by 12
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary
|Circulation|2012|2.4k
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
|New England Journal of Medicine|2012|2.3k